stars 1 stars 2 stars 3

EmboMedics is an early stage medical technology company spun out of the University of Minnesota and now completing development of its first product. The Company's technology was developed by the Division Head - Interventional Radiology and Vascular Imaging at UMN and is targeted at the field of arterial embolization to treat, among other things, liver cancer. EmboMedics has created a new bioresorbable, drug loadable embolic bead technology designed to block blood vessels supplying tumors and then resorb to enable the reuse of those vessels for needed drug delivery. The EmboMedics product line will include both bland and drug loadable iterations designed for optimal absorbtion and drug delivery profiles for treating cancer and other disease states.

EmboMedics Questions

The EmboMedics annual revenue was $1.2 million in 2026.

EmboMedics is based in Golden Valley, Minnesota.

The NAICS codes for EmboMedics are [32541, 325, 3254, 32].

The SIC codes for EmboMedics are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users